Bluebook
Pharma Services Blue Book September 2024
2024 - September: Report on M&A and financing activity in the pharma services drug development industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Highlights from this edition:
- Vectura Group was acquired by Molex Asia Holdings
- Better Choice Company Inc. (NYSEAM:BTTR) announced its acquisition of SRx Health Solutions
- Chai Discovery closed a $30MM Series A Financing, led by Kleiner Perkins Caufield & Byers, Thrive Capital Management, Amplify Partners, OpenAI, Neo, Conviction Partners